comparemela.com

Latest Breaking News On - Andrews davis - Page 2 : comparemela.com

Silk Road Medical (NASDAQ:SILK) Releases Quarterly Earnings Results, Beats Expectations By $0.04 EPS

Silk Road Medical (NASDAQ:SILK – Get Free Report) announced its quarterly earnings data on Tuesday. The company reported ($0.36) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.40) by $0.04, Briefing.com reports. The business had revenue of $48.50 million for the quarter, compared to the consensus estimate of $44.67 million. Silk […]

United-states
Kevinj-ballinger
Andrews-davis
Piper-sandler
Stifel-nicolaus
Securities-exchange-commission
Jpmorgan-chase-co
Nasdaq
Silk-road-medical
Get-free-report
Road-medical
Road-medical-trading-down

Peregrine Capital Management LLC Sells 338,639 Shares of Silk Road Medical, Inc (NASDAQ:SILK)

Peregrine Capital Management LLC trimmed its position in shares of Silk Road Medical, Inc (NASDAQ:SILK – Free Report) by 99.1% during the 4th quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 3,200 shares of the company’s stock after selling 338,639 shares during the quarter. Peregrine […]

New-york
United-states
Andrews-davis
Piper-sandler
Stifel-nicolaus
Kevinj-ballinger
Algert-global
Securities-exchange-commission
Peregrine-capital-management
York-state-common-retirement-fund
Jpmorgan-chase-co
Nasdaq

Silk Road Medical, Inc (NASDAQ:SILK) Receives $22.18 Average Target Price from Brokerages

Silk Road Medical, Inc (NASDAQ:SILK) Receives $22.18 Average Target Price from Brokerages
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

Alger
Algeria
United-states
Andrews-davis
Stifel-nicolaus
Piper-sandler
Dmariel-jones
Fred-alger-management
Goldman-sachs-group-inc
Securities-exchange-commission
Nasdaq
Jpmorgan-chase-co

Piper Sandler Trims Silk Road Medical (NASDAQ:SILK) Target Price to $11.00

Silk Road Medical (NASDAQ:SILK – Free Report) had its price target cut by Piper Sandler from $25.00 to $11.00 in a research report sent to investors on Wednesday, Benzinga reports. They currently have a neutral rating on the stock. Several other research analysts have also weighed in on the company. Stifel Nicolaus lowered Silk Road […]

United-states
Lucasw-buchanan
Piper-sandler
Andrews-davis
Advisornet-financial-inc
Wells-fargo-company
Wolfe-research
Company-profile
Nasdaq
Financial-services-group-inc
Us-bancorp
Silk-road-medical

Silk Road Medical, Inc (NASDAQ:SILK) Receives $37.60 Average Target Price from Brokerages

Silk Road Medical, Inc (NASDAQ:SILK – Get Free Report) has earned a consensus rating of “Hold” from the nine research firms that are currently covering the company, MarketBeat Ratings reports. Two research analysts have rated the stock with a sell rating, two have issued a hold rating and five have assigned a buy rating to […]

Alger
Algeria
United-states
Zurich
Züsz
Switzerland
America
Andrews-davis
Kevinm-klemz
Stifel-nicolaus
Citigroup
Wolfe-research

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.